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ABSTRACT
Two analytical methods for the quality control of dihydrocodeine in 
commercial pharmaceutical formulations have been developed and 
compared with reference methods: a square wave voltammetric 
(SWV) method and a ﬂow injection analysis system with electroche-
mical detection (FIA-EC). The electrochemical methods proposed
were successfully applied to the determination of dihydrocodeine in
pharmaceutical tablets and in oral solutions. These methods do not
require any pretreatment of the samples, the formulation only being
dissolved in a suitable electrolyte. Validation of the methods showed
it to be precise, accurate and linear over the concentration range of
analysis. The automatic procedure based on a ﬂow injection analysis
manifold allows a sampling rate of 115 determinations per hour.
Key Words: Dihydrocodeine; Square wave voltammetry; Flow
injection analysis with electrochemical detection; FIA.
1. INTRODUCTION
Dihydrocodeine (DHC) is a semisynthetic opioid that is frequently
used as a moderately potent analgesic and antitussive agent (Fig. 1).
Although dihydrocodeine is structurally related to the natural occurring
opioid codeine it has 2–4 times more potent analgesic activity. Dihydro-
codeine has been nominated by the World Health Organisation as a
second-step drug in therapeutic strategy for cancer pain relief.[1] Further-
more, doses up to 2500mg per day are prescribed in substitution therapy
for heroin drug addicted people.
Despite dihydrocodeine being used as active substance in a variety of
pharmaceutical preparations available in the market, it is surprising that
few analytical methods were proposed for its determination.
Most of the methodologies proposed for dihydrocodeine determina-
tion, namely GC,[2,3] HPLC,[4,5] capillary electrophoresis[6] and immuno-
logical assays,[6,7] have been used for pharmacokinetic studies or forensic
screening in biological samples such as plasma, blood or urine. Assay
Figure 1. Structure of dihydrocodeine.
methods reported in the British[8] and United States[9] Pharmacopoeias
for dihydrocodeine determination in pharmaceutical preparations are
based on extraction of the base followed by nonaqueous titrimetry and
in HPLC, the last technique also being the most proposed in the literature
for quantiﬁcation of this compound.[10,11]
Electroanalytical techniques have proved for a long time to be very
useful methodologies due to their sensitivity and low operating costs.
Although some of the HPLC methods proposed use an electrochemical
detector[4] few electrochemical studies concerning dihydrocodeine have
been reported.[12] Indeed, this could be due to the fact that until the
middle 80s it was stated in the literature that codeine, the starting mate-
rial used to produce dihydrocodeine after reduction of the 7,8-double
bond, is devoid of electroactivity.
In order to develop a method adequate for routine analysis that
could surpass some of the drawbacks of the proposed methodologies,
e.g., time consuming and with intensive solvent usage, sophisticated
instruments and training, an electrochemical study of the behavior of
dihydrocodeine at a glassy carbon electrode has been carried out. The
results obtained enabled the development of a square-wave voltammetric
(SWV) method, and of an alternative analytical method that combines
the advantages of amperometric detection with those of ﬂow injection
analysis (FIA-EC). Both methods were applied to the determination of
dihydrocodeine in commercial pharmaceutical preparations available in
the market without submitting the samples to any pretreatment other
than dissolution.
2. MATERIALS AND METHODS
2.1. Equipment
Voltammetric measurements were carried out using a 663 VA
Metrohm cell containing a glassy carbon working electrode (Metrohm,
Switzerland, d¼ 2.0mm), a glassy carbon rod counter electrode
(Metrohm, Switzerland) and an Ag/AgCl (3M KCl) reference electrode
(Metrohm, Switzerland) attached to an Autolab PSTAT 10 potentio-
stat/galvanostat running with GPES software (EcoChimie, Netherlands).
The FIA manifold (Fig. 4) consists of a Gilson Minipuls 3 peristaltic
pump (Gilson, France) to propel the solutions, a Rheodyne 5020 valve
(Rheodyne, Berkely, CA) to inject the solutions and an electrochemical
detector system consisting of a VA 641 Metrohm detector and a 656
Metrohm electrochemical wall-jet cell (Metrohm, Switzerland). This cell
contains three electrodes, a Metrohm glassy carbon working electrode, a
Metrohm gold auxiliary electrode and a Metrohm Ag/AgCl (3M KCl)
reference electrode. Omniﬁt Teﬂon tubing (0.8mm i.d.) (Omniﬁt,
Cambridge, UK) and Gilson end ﬁttings as well as homemade dampers
drilled from perspex[13] were used to connect the manifold components. A
Kipp & Zonen (model BD 112) data recorder was used to register the
analytical signals (Kipp & Zonen, Netherlands).
The glassy carbon working electrodes were manually cleaned and
polished on an abrasive surface every day, with 1 mm particle size
Al2O3 (BDH, England) and then rinsed carefully with deionized water.
A Metrohm E520 pH-meter with glass electrode was used for the pH
measurements (Metrohm, Switzerland).
For the HPLC reference method,[8,9] a Sykam model A 1210 liquid
chromatograph (Sykam, Germany), equipped with an UV detector
(¼ 284 nm) model 3200 was used. Separation of sample components
was accomplished using a Nucleosil 120-5 C18 column (250 4mm,
5 mm particle size, Macherey-Nagel, Germany). The analysis was carried
out at room temperature using 0.01M sodium acetate and 0.005M dioc-
tyl sodium sulphosuccinate mixed in 60 volumes of methanol plus 40
volumes of water as mobile phase, at a ﬂow rate of 1.5mL per minute,
the pH of the mixture being adjusted to 5.5 with glacial acetic acid.
2.2. Chemicals and Solutions
Dihydrocodeine bitartrate was kindly provided by Knoll Lusitana
(Prior Velho, Portugal). Analytical grade reagents purchased from
Merck (Darmstadt, Germany) were used without additional puriﬁcation.
Deionised water (conductivity <0.1 mS cm1) was used throughout. The
pH 3 acetate buﬀer used for voltammetric determinations was prepared
by dilution to 100mL of 3.7mL of 0.2M sodium acetate and 46.3mL of
0.2M acetic acid. The pH 6 supporting electrolyte used as carrier in the
FIA system was prepared by dilution to 100mL of 6.2mL of 0.2M
dipotassium hydrogen phosphate and 43.8mL of 0.2M potassium dihy-
drogen phosphate. In the HPLC reference method all the solvents used,
purchased from Merck (Darmstadt, Germany), were of HPLC grade.
Prior to use, the solvents were ﬁltered and the air removed with helium.
The determination of dihydrocodeine in commercial formulations
was carried out on Didor Continus tablets (Asta Medica, Lisbon,
Portugal), Paracodina tablets (Knoll, Prior Velho, Portugal) and
Paracodina N oral solution (Knoll, Prior Velho, Portugal); for the
nominal content of the labeled dihydrocodeine see Table 3.
2.3. Standard and Sample Solutions
A standard stock solution of dihydrocodeine bitartrate at a con-
centration of 1mM was prepared by dissolving the appropriate amount
of dihydrocodeine bitartrate in 0.01MHClO4.
In the voltammetric method accurate volumes of the stock standard
solution were added, in the voltammetric cell, to pH 3 buﬀer solution in
order to obtain dihydrocodeine concentrations between 40 and 140 mM.
For the FIA system, more dilute solutions, between 7 and 50 mM,
were prepared by appropriate dilution of the stock solution with pH 6
supporting electrolyte. All solutions were prepared daily.
Preparation of samples for analysis was carried out as follows:
ten tablets were weighed to determine the average tablet weight
and ﬁnely powdered in an agate mortar. An accurately weighed
powder sample, appropriate to obtain a concentration of dihydrocodeine
within the calibration curve range, was carefully dissolved in acetate
buﬀer pH 3 (SW determination) or phosphate buﬀer pH 6 (FIA determi-
nation).
A suitable volume of oral solution was just diluted with buﬀer
solution to achieve the appropriate concentration.
2.4. Validation of the Analytical Methods
Once the square wave and ﬂow injection experimental conditions
were established methods for validation were performed.
The linearity of the methods was determined by building calibration
curves. For the square wave voltammetric method a six-point calibration
curve was set up by plotting peak currents of the oxidation peak against
dihydrocodeine standard solution concentrations, in the 40–140 mM
range. In the ﬂow injection method analyses were performed by injecting
dihydrocodeine standard solutions in the 7–50 mM range. A six-point
calibration curve was set up by plotting the values of dihydrocodeine
peak heights against dihydrocodeine concentrations.
The limit of quantiﬁcation (LOQ) and the limit of detection (LOD)
were calculated according to USP XXIV guidelines.[9] A S/N ratio of ten
and three were used respectively.
Method precision was determined by replicate determinations of
three diﬀerent concentration levels of dihydrocodeine. Intraday repeat-
ability was studied by carrying out ﬁve measurements for each level on
the same day. Interday repeatability was obtained by performing three
determinations for each concentration on ﬁve consecutive days.
The accuracy of the proposed methods was determined by comparing
the results obtained with those from reference methods.[8,9] A reversed-
phase HPLC with UV detection and a nonaqueous titrimetric method
were used for oral solution and tablets, respectively.
3. RESULTS AND DISCUSSION
3.1. Eﬀect of pH
The electrochemical oxidation of dihydrocodeine at a glassy carbon
electrode was studied over a very wide pH range by diﬀerential pulse
voltammetry (Fig. 2). The oxidation always occurs at very high positive
potentials, making impossible the use of platinum or gold as working
electrodes.
The oxidation mechanism of dihydrocodeine is complex with adsorp-
tion occurring at the electrode surface and is pH dependent. At very
acidic pH only one oxidation peak can be observed. For pH between 3
and 7 two oxidation peaks are seen and at pH above 7 three peaks can be
detected. The position of all peaks was pH dependent. Due to the very
Figure 2. Plots of Ep (ﬁlled symbols) and Ip (open symbol) vs. pH from diﬀer-
ential pulse voltammograms of 0.1mM solutions of dihydrocodeine in 0.2M ionic
strength buﬀer electrolyte: (g œ) ﬁrst peak, (m), second peak, (^) third peak.
Scan rate 5mV s1.
high positive potentials necessary, detection of the peaks with higher
potentials is limited by solvent evolution. Considering the current for
the ﬁrst oxidation peak, it reaches a maximum value at pH¼ 6 (Fig. 2).
3.2. Square Wave Voltammetric Method
Square wave voltammetry (SWV) was used to develop a voltam-
metric method for the determination of dihydrocodeine in commercial
pharmaceutical preparations, since this pulse voltammetric mode is
highly expeditious and sensitive. As seen in Fig. 2, the oxidation of
dihydrocodeine is a complex mechanism and three oxidation peaks can
be observed at high pH. Although the highest peak current intensity was
observed at pH 6, in order to minimize the eventual fouling of the
electrode surface by adsorption of the products of the possible three
oxidation processes a buﬀer supporting electrolyte of pH 3 was selected
for subsequent studies since at this pH only one peak appears (Fig. 3).
The inﬂuence of the square wave frequency ( f ), pulse amplitude (Es)
and ionic strength (I ) was assessed with a view to optimization of the
experimental conditions. Optimized parameters found were f¼ 150Hz,
Es¼ 50mV and I¼ 0.2M, and good linearity was obtained in the
Figure 3. Successive square wave voltammograms, in pH 3 0.2M buﬀer electro-
lyte, of dihydrocodeine standard solutions: 40.6, 60.6, 80.4, 100, 119 and 139mM.
Frequency 150Hz; pulse amplitude 50mV.
40–140 mM dihydrocodeine concentration range (Fig. 3). The linearity
equation obtained by means of the least square method was
y¼ 1.7 102 xþ 2.0 107 with a correlation coeﬃcient higher than
0.999. The coeﬃcient of variation of the slope and intercept was 1.4
and 0.9%, respectively (Table 1). The LOQ and LOD, calculated accord-
ing to USP XXIV guidelines,[9] were 14 and 4 mM, respectively. Precision
assays were carried out at three levels (40, 80 and 140 mM) and the results
were good; the RSD% values obtained ranged from 1.2 to 2.1% for
repeatability (intraday precision) and from 1.8 to 2.9% for intermediate
(interday) precision (Table 1).
3.3. Flow Injection Analysis with Electrochemical Detection
A ﬂow injection analysis manifold with electrochemical detection
(FIA-EC) system was developed in order to quantify dihydrocodeine in
pharmaceutical preparations, optimizing each variable parameter sepa-
rately and ﬁxing the remainder. The aim was ﬁnding the best conditions
in terms of sensitivity, reproducibility and sampling rate. Hence, a single
channel manifold was set up (Fig. 4) and the inﬂuences of the working
Table 1. Linearity range, quantiﬁcation and detection limits and
intraday and interday repeatability for determination of
dihydrocodeine using the square wave voltammetric method (SWV).
SWV
Linearity range (mM) 40–140
SlopeaRSD% 1.7 102 1.4
InterceptaRSD% 2.0 107 0.9
Intraday precision (RSD%)b
40 mM 1.6
80 mM 2.1
140 mM 1.2
Interday precision (RSD%)b
40 mM 2.9
80 mM 2.5
140 mM 1.8
LOQ (mM) 14
LOD (mM) 4
aMean (n¼ 3).
bMean (n¼ 5).
electrode potential, the ﬂow rate (Q1), the injection volume (A) and the
length of the reactor (R) were assessed separately. In these experiments to
determine the best working conditions of the FIA manifold a 100 mM
solution of dihydrocodeine was used.
The use of low concentrations in this ﬂow system and the brief con-
tact between the sample and the electrode surface drastically reduce the
possibility of fouling caused by adsorption processes. Since it was known
from the diﬀerential pulse voltammetric study that the highest current is
obtained for pH 6 (Fig. 2) it was decided to use this as the buﬀer support-
ing electrolyte for further studies.
To optimize the working electrode potential the variation of the
current peak height with applied potential in the range þ1.2 to þ1.5V
was studied. The highest value for the current peak was obtained for
þ1.3V and so this was used subsequently.
The best ﬂow rate depends on the characteristics of the electroche-
mical detector whose small dead volume (approximately 1 mL[14]) does
not permit the use of very high ﬂow rates. Our studies showed that too
high ﬂow rates lead to high pressures inside the system, causing irrepro-
ducible signals, and low ﬂow rates compromised sampling rates. Taking
this into account, the value of 2.4mLmin1 at the entry of the detector
was chosen.
Once the ﬂow rate had been optimised, the best injection volume was
established by testing diﬀerent loops, constructed with the same Teﬂon
tubing used for the other parts of the system (0.8mm i.d.), with lengths
between 5 and 20 cm. A 10 cm loop was chosen since larger loops reduced
the sampling rate whereas smaller loops produced less reproducible ana-
lytical signals. The injection volume corresponding to this 10 cm loop was
accurately determined by titration of a solution of known concentration
and was 78 mL.[15]
Figure 4. Flow injection analysis manifold used for dihydrocodeine deter-
mination: A—sample, B—peristaltic pump, E-inlet for pH 6 K2HPO4/KH2PO4
buﬀer supporting electrolyte, Q1—ﬂow rate 2.4mLmin1, V—injection valve
(78mL), R—mixing coil (30 cm), WJD—wall-jet electrochemical detector, D—
outlet for waste.
The optimization of the system concluded with the optimization of
the reactor length (R) between the injection valve and the detector.
Diﬀerent lengths of reactor (teﬂon tubing 0.8mm i.d.) were tested,
between 20 and 40 cm, 30 cm being selected regarding reproducibility,
sensitivity and sampling rate.
The ﬂow injection methodology developed led to very reproducible
results (Fig. 5). Using these optimized parameters a calibration curve was
set up with standard solutions in the 7 – 50 mM concentration range. The
least-square regression equation was y¼ 9.3 10 x4þ 0.4 with a correla-
tion coeﬃcient higher than 0.999. The coeﬃcient of variation of the slope
was 1.1% and of the intercept 0.6% (Table 2). The LOQ obtained was
3 mM and the LOD was 1 mM. Precision assays were carried out at three
levels (7, 20 and 50 mM) and the results were very good; RSD% values
ranged from 0.5 to 1.0% for repeatability and from 0.9 to 1.8% for
intermediate precision (Table 2). This FIA manifold enabled sampling
rates of about 115 samples per hour.
Figure 5. Flow injection analysis with electrochemical detection of mM dihydro-
codeine standard solutions: A—6.64, B—9.97, C—19.9, D—29.9, E—39.9, F—
49.8, and pharmaceutical samples: G—Didor, H—Paracodina and I—Paracodina
N, under the experimental conditions described.
3.4. Determination of Dihydrocodeine in
Pharmaceutical Preparations
Dihydrocodeine is orally administered either in liquid or solid form.
There are three commercial pharmaceutical preparations available in
Portugal containing dihydrocodeine (Table 3) two in the form of tablets
and one as oral solution. In all these preparations dihydrocodeine is the
only active substance and the other components do not give a signiﬁcant
signal under the experimental electrochemical conditions used in the
SWV and FIA-EC determinations.
For the voltammetric method, SW voltammograms were recorded
for diﬀerent dihydrocodeine standards in the concentration interval
40–140 mM (Fig. 3) and for the commercial samples.
The FIA-EC system was calibrated by three replicate injections of six
dihydrocodeine standards in a concentration range between 7 and 50 mM.
Figure 5 shows the injection in triplicate of the standard solutions and
pharmaceutical preparations.
The results obtained were compared with those obtained by the
reference methods,[8,9] to evaluate the accuracy of these techniques.
Table 2. Linearity range, quantiﬁcation and detection
limits and intraday and interday repeatability for
determination of dihydrocodeine using FIA with
electrochemical detection system (FIA-EC).
FIA-EC
Linearity range (mM) 7–50
SlopeaRSD% 9.3 104 1.1
InterceptaRSD% 0.4 0.6
Intraday precision (RSD%)b
7mM 1.0
20mM 0.8
50mM 0.5
Interday precision (RSD%)b
7mM 1.8
20mM 1.6
50mM 0.9
LOQ (mM) 3
LOD (mM) 1
aMean (n¼ 3).
bMean (n¼ 5).
Table 3 lists the mean results obtained for ﬁve replicate determinations of
the pharmaceutical preparations tested. The results obtained were com-
pared statistically by Student’s t-test and Variance ratio F-test (Table 3).
The experimental values did not exceed the theoretical values in either
tests, which indicates that there was no signiﬁcant diﬀerence between the
methods compared.
4. CONCLUSIONS
The electrochemical methodologies developed are shown to be
valuable for the determination of dihydrocodeine with good accuracy
and precision. They show a similar reproducibility to the oﬃcial methods
but they are faster and cheaper than those employed in pharma-
ceutical analytical control laboratories. In particular, the ﬂow injection
system enables the determination of dihydrocodeine in pharmaceutical
preparations at a rate of 115 samples per hour.
Complex pretreatment of the samples is avoided since the prepara-
tion of the pharmaceutical preparations simply involves dissolution in an
electrolyte. The results obtained therefore suggest that these methods
could replace time-consuming and costly procedures and could be
easily used in quality control processes.
Table 3. Determination of dihydrocodeine in commercial pharmaceutical
formulations using the square wave voltammetric method (SWV), FIA with
electrochemical detection (FIA-EC) and reference methods.
Formulation
Dihydrocodeine
nominal content SWVa FIA-ECa
Reference
methoda
Didor Continus 60mg/tablet 59.9 0.3 60.5 0.3 60.1 0.5
tb 0.5 0.4
Fc 2.8 2.8
Paracodina 10mg/tablet 10.2 0.3 10.1 0.2 10.1 0.4
tb 0.7 0.4
Fc 1.8 4.0
Paracodina N 12mg/5mL 11.8 0.2 12.1 0.2 11.9 0.1
tb 0.8 0.3
Fc 4.0 4.0
aMean and standard deviations of ﬁve determinations (mg/tablet or mg/5 mL).
bTabulated t-value for P¼ 0.05 and eight degrees of freedom is 2.306.
cTabulated F-value for P¼ 0.05 and f1¼ f2¼ 4 is 6.39.
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